Not every drug that has reached human clinical trials has needed preliminary nonclinical studies to demonstrate safety. This podcast episode is a case study for replacing the use of animals during the safety testing that occurs prior to human clinical trials, in which our guest speaker reviews conversations with regulatory authorities regarding a modern nonanimal testing strategy utilized to bring a nonequine-derived antitoxin as a therapeutic product to a patient.
ToxChats© episodes report on cutting-edge news in toxicological research from around the globe, and feature interviews with experts and reviews of current advances in toxicology. Tune in to learn about breakthroughs and regulatory developments in toxicological research, and more! We welcome any feedback or suggestions for future topics.
#ToxChats